Choice Hotels International: Price Target Trimmed, But Still A Buy

Choice Hotels International (CHH) delivered mixed Q2 FY2025 results, experiencing RevPAR declines that were largely offset by growth in rooms and higher royalty rates, contributing to resilient cash flow. The company's strategic focus on defensively strong Extended Stay and Economy segments, coupled with international expansion and the acquisition of Choice Canada, positions it for future growth. Despite lowered guidance and an analyst trimming the price target to $145, a 'Buy' rating is maintained, projecting approximately 20% annual total returns from appreciation and buybacks.

Analysis

Choice Hotels International (CHH) delivered mixed Q2 FY2025 results, where a decline in Revenue Per Available Room (RevPAR) was offset by compensatory growth in its room portfolio and higher royalty rates, culminating in resilient cash flow. The company's strategic positioning in the defensive Extended Stay and Economy segments continues to show strength, providing a buffer against economic headwinds. Future growth is predicated on international expansion, with notable efforts in China and Poland, and the recent acquisition of Choice Canada, which enhances operational control and supports room and royalty growth. Despite these positive operational metrics, the company lowered its forward guidance, leading to a reduction in its analyst price target to $145. Nevertheless, the analyst maintains a 'Buy' rating, projecting a potential 20% annual total return driven by a combination of share price appreciation and stock buybacks.

Key Decisions for Investors

• Investors should weigh the near-term headwind of declining RevPAR against the company's resilient cash flow and the offsetting growth in room count and royalty rates.
• Consider the long-term growth potential stemming from international expansion and the strategic benefits of the Choice Canada acquisition, which are central to the bullish thesis.
• Despite lowered guidance and a reduced price target to $145, the reiterated 'Buy' rating and projected 20% annual return suggest the current valuation could be an entry point for those aligned with the analyst's positive outlook on the company's defensive segments and capital return program.